{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T05:06:07Z","timestamp":1764047167783,"version":"3.40.5"},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"46","license":[{"start":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T00:00:00Z","timestamp":1668729600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,11,18]]},"abstract":"<jats:sec>\n            <jats:title>Introduction:<\/jats:title>\n            <jats:p>Chronic pruritus persists for\u2005&gt;\u20056 weeks and is known to decrease patients\u2019 quality of life. Due to the complex pathological mechanism of chronic pruritus, there is still a lack of satisfactory therapeutic agents; therefore, complementary therapies are required to improve itching symptoms. In the Republic of Korea, <jats:italic toggle=\"yes\">Sopoongsan<\/jats:italic>, an herbal formula, has been used to treat itching, dizziness, and skin paralysis. To our knowledge, this is the first study to evaluate whether <jats:italic toggle=\"yes\">Sopoongsan<\/jats:italic> improves chronic pruritus and to identify <jats:italic toggle=\"yes\">Sopoongsan<\/jats:italic>-related changes in the immune response in patients with chronic upper body pruritus.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>A randomized, double-blind, placebo-controlled parallel trial will be conducted to assess 20 patients with chronic upper body pruritus for 3 months who have been diagnosed with allergic atopic dermatitis or seborrheic dermatitis. The patients will be randomly allocated to either the placebo-control (n\u2005=\u200510) or treatment (n\u2005=\u200510) group. The total study period will be 8 weeks (i.e., administration of <jats:italic toggle=\"yes\">Sopoongsan<\/jats:italic> or placebo drugs for 4\u2009wk and follow-up for 4\u2009wk). Participants will be allowed to receive external treatment, except for antipruritic medications administered orally, throughout the study period. The primary outcome measure will be the numeric rating scale results for itching, whereas the secondary outcome measures will be questionnaire survey (Dermatological Life Quality Index and Epworth Sleepiness Scale) findings and the immune response index, including interferon gamma, interleukin-4, immunoglobulin E, thymic stromal lymphopoietic protein, and histamine, to investigate the biological mechanisms underlying chronic pruritus.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Discussion and Conclusions:<\/jats:title>\n            <jats:p>We expect that the results of this study will provide important clinical evidence regarding the effectiveness of <jats:italic toggle=\"yes\">Sopoongsan<\/jats:italic> on itching symptoms, quality of life, sleep disturbance, and changes in the immune response. The findings will help elucidate the mechanism underlying the therapeutic effect of <jats:italic toggle=\"yes\">Sopoongsan<\/jats:italic> for chronic pruritus and lay the foundation for further studies in this area.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000031470","type":"journal-article","created":{"date-parts":[[2022,11,30]],"date-time":"2022-11-30T22:05:16Z","timestamp":1669845916000},"page":"e31470","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Effectiveness of Sopoongsan for chronic upper body pruritus in patients with atopic or seborrheic dermatitis: A pilot study protocol for a randomized, double-blind, placebo-controlled, parallel trial"],"prefix":"10.1097","volume":"101","author":[{"given":"Jung-Hee","family":"Jang","sequence":"first","affiliation":[{"name":"Clinical Medicine Division, Korea Institute of Oriental Medicine, Daejeon, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Purumea","family":"Jun","sequence":"additional","affiliation":[{"name":"Clinical Medicine Division, Korea Institute of Oriental Medicine, Daejeon, Republic of Korea"},{"name":"University of Science and Technology (UST), Campus of Korea Institute of Oriental Medicine, Korean Convergence Medical Science major, Daejeon, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gunhyuk","family":"Park","sequence":"additional","affiliation":[{"name":"Herbal Medicine Resources Research Center3, Korea Institute of Oriental Medicine, Jeollanam-do, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ojin","family":"Kwon","sequence":"additional","affiliation":[{"name":"Clinical Medicine Division, Korea Institute of Oriental Medicine, Daejeon, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yujin","family":"Choi","sequence":"additional","affiliation":[{"name":"Clinical Medicine Division, Korea Institute of Oriental Medicine, Daejeon, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hye-Sun","family":"Lim","sequence":"additional","affiliation":[{"name":"Herbal Medicine Resources Research Center3, Korea Institute of Oriental Medicine, Jeollanam-do, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Byeong Cheol","family":"Moon","sequence":"additional","affiliation":[{"name":"Herbal Medicine Resources Research Center3, Korea Institute of Oriental Medicine, Jeollanam-do, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3802-8717","authenticated-orcid":false,"given":"Kyuseok","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Otolaryngology and Dermatology of Korean Medicine, College of Korean Medicine, Kyung Hee University, Seoul, Republic of Korea."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1056\/NEJMcp1208814","article-title":"Clinical practice. Chronic pruritus.","volume":"368","author":"Yosipovitch","year":"2013","journal-title":"N Engl J Med"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.jdermsci.2019.05.008","article-title":"Long-term safety and efficacy of rupatadine in Japanese patients with itching due to chronic spontaneous urticaria, dermatitis, or pruritus: a 12-month, multicenter, open-label clinical trial.","volume":"94","author":"Hide","year":"2019","journal-title":"J Dermatol Sci"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.det.2018.02.014","article-title":"Immunomodulating agents as antipruritics.","volume":"36","author":"Erickson","year":"2018","journal-title":"Dermatol Clin"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nn.3619","article-title":"Why we scratch an itch: the molecules, cells and circuits of itch.","volume":"17","author":"Bautista","year":"2014","journal-title":"Nat Neurosci"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.jaad.2018.02.030","article-title":"Serlopitant for the treatment of chronic pruritus: results of a randomized, multicenter, placebo-controlled phase 2 clinical trial.","volume":"78","author":"Yosipovitch","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ctim.2013.12.003","article-title":"Characteristics and prescription patterns of traditional Chinese medicine in atopic dermatitis patients: ten-year experiences at a medical center in Taiwan.","volume":"22","author":"Lin","year":"2014","journal-title":"Complement Ther Med"},{"key":"R7-20250504","first-page":"347164","article-title":"Identifying Chinese herbal medicine network for eczema: implications from a nationwide prescription database.","volume":"2015","author":"Chen","year":"2015","journal-title":"Evid Based Complement Alternat Med"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.jep.2015.04.002","article-title":"Chinese herbal medicine network and core treatments for allergic skin diseases: Implications from a nationwide database.","volume":"168","author":"Chen","year":"2015","journal-title":"J Ethnopharmacol"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/s12906-016-1158-1","article-title":"Characteristics of traditional Chinese medicine users and prescription analysis for pediatric atopic dermatitis: a population-based study.","volume":"16","author":"Chen","year":"2016","journal-title":"BMC Complement Altern Med"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1159\/000318861","article-title":"The efficacy and safety of a Chinese herbal product (Xiao-Feng-San) for the treatment of refractory atopic dermatitis: a randomized, double-blind, placebo-controlled trial.","volume":"155","author":"Cheng","year":"2011","journal-title":"Int Arch Allergy Immunol"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.3389\/fphar.2018.01474","article-title":"The efficacy and safety of a fixed combination of Chinese herbal medicine in chronic urticaria: a randomized, double-blind, placebo-controlled pilot study.","volume":"9","author":"Yang","year":"2018","journal-title":"Front Pharmacol"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.alit.2016.08.009","article-title":"Assessment of severity and burden of pruritus.","volume":"66","author":"Pereira","year":"2017","journal-title":"Allergol Int"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1111\/j.1365-2125.2012.04350.x","article-title":"Herb-drug interactions: a overview of systematic reviews.","volume":"75","author":"Posadzki","year":"2013","journal-title":"Br J Clin Pharmacol"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1001\/jama.1968.03140330034006","article-title":"Licorice-induced pseudoaldosteronism. Hypertension, hypokalemia, aldosteronopenia, and suppressed plasma renin activity.","volume":"205","author":"Conn","year":"1968","journal-title":"JAMA"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"86","DOI":"10.18433\/jpps30847","article-title":"Topical application of doxycycline inhibits Th2 cell development mediated by Langerhans cells and exerts a therapeutic effect on atopic dermatitis.","volume":"23","author":"Matsui","year":"2020","journal-title":"J Pharm Pharm Sci"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000031470","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T05:04:32Z","timestamp":1746335072000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000031470"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,18]]},"references-count":15,"journal-issue":{"issue":"46","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000031470","relation":{},"ISSN":["1536-5964"],"issn-type":[{"type":"electronic","value":"1536-5964"}],"subject":[],"published":{"date-parts":[[2022,11,18]]}}}